Sponsors & CROs

Embedded Clinical Execution for Sponsors and CROs

Research Management Partners (RMP) is an embedded SMO–MSO clinical research organization designed to reduce execution risk and operational variability across multi-site clinical trials.

We operate directly within active clinical practices—integrating investigators, coordinators, and research infrastructure under a centralized operational framework that ensures consistent study delivery at the site level.

A Model Built to Control Execution

Traditional site networks aggregate sites.
RMP controls execution within them.

By embedding research operations directly into clinical environments, we standardize workflows, enforce SOP compliance, and maintain real-time oversight across all participating sites.

This enables Sponsors and CROs to transition from fragmented execution to controlled, predictable study performance.

Integrated Oncology & Advanced Clinical Capabilities

RMP is actively expanding its oncology infrastructure, integrating hemato-oncology and radiation oncology capabilities within its embedded network.

Our oncology model supports:

Multidisciplinary coordination across oncology specialties
Advanced imaging integration and treatment workflows
Biomarker-driven patient identification and enrollment
Readiness for complex protocols, including radiopharmaceuticals and targeted therapies

In parallel, RMP collaborates with established laboratory partners with extensive experience in biospecimen collection, processing, and storage—supporting clinical trials requiring high-quality sample handling, chain-of-custody control, and protocol-specific laboratory workflows.

Our Operational Model

Unified SOP governance across all affiliated sites framework aligned with ICH-GCP and ALCOA.
Centralized regulatory, star-up and quality oversight and management
Embedded execution within active medical clinics

Performance & KPIs

Accelerated IRB submissions (typically 1–2 weeks)
Predictable site activation timelines
High patient retention driven by continuity of care
Rapid query resolution and audit readiness
Embedded site teams operating withing active practices.

Therapeutic Scope & Research Capabilities

Research Management Partners (RMP) supports clinical research across a broad range of therapeutic areas through an embedded network of investigators, specialists, and actively managed clinical practices.

Unlike traditional site networks, RMP integrates research operations directly within multi-specialty clinics—enabling Sponsors and CROs to access diverse patient populations while maintaining controlled execution, standardized processes, and real-time oversight across all therapeutic programs.

Core Therapeutic Capabilities

RMP supports Phase I–IV clinical trials across multiple therapeutic areas, including:

• Psychiatry and Behavioral Health
• Gastroenterology
• Pulmonology and Respiratory Diseases
• Internal Medicine
• Rheumatology and Autoimmune Disorders
• Cardiology
• Endocrinology and Metabolic Conditions
• Infectious Diseases
• Dermatology
• Nephrology

Expanding Oncology Capabilities

RMP is actively expanding its oncology infrastructure, integrating hemato-oncology and radiation oncology capabilities within its embedded model.

This includes:

Multidisciplinary oncology teams
Support for advanced imaging and treatment workflows
Biomarker-driven patient identification
Readiness for complex protocols, including radiopharmaceuticals and targeted therapies

Beyond Traditional Clinical Trials

In addition to interventional and observational studies, RMP supports:

Biospecimen and sample collection programs
Patient registries and longitudinal studies
Real-world evidence (RWE) initiatives
Research programs requiring integrated clinical workflows

Through access to diverse patient populations and embedded clinical environments, RMP enables efficient study execution while maintaining high standards of patient safety, protocol compliance, and data integrity.

When Sponsors Engage RMP

Sponsors and CROs typically engage RMP when:

Study timelines are delayed or at risk
Enrollment is underperforming
Multi-site execution lacks consistency
Protocol adherence requires stronger oversight
A centralized execution partner is needed

Execution That Drives Outcomes

Clinical trials do not fail due to lack of sites—they fail due to inconsistent execution.

RMP was built to solve this problem by embedding operational discipline, real-time oversight, and standardized execution directly into the clinical environments where research is conducted.

SPONSOR VALUE

Our embedded SMO model reduces monitoring burden while enhancing operational control, protocol compliance, and data reliability across all sites. Through centralized oversight and continuous on-site execution, RMP delivers predictable enrollment performance, improved data integrity, and scalable multi-site trial execution—reducing operational risk and accelerating study timelines.

Supporting sponsors and CROs with reliable execution, scalable infrastructure, and consistent site performance across diverse patient populations.

Case Study: Accelerated Patient Enrollment Through Embedded Site Network

A multi-site clinical study requiring rapid patient enrollment was supported through the RMP embedded SMO network across South Florida. Leveraging direct access to pre-existing patient populations within active medical practices, sites were able to initiate targeted pre-screening immediately upon study activation.

Using EMR-based identification aligned with protocol-specific criteria, combined with physician-led recruitment and centralized CTMS oversight, RMP enabled efficient patient identification and engagement across participating sites.

This approach resulted in consistent screening activity, improved patient retention, and predictable enrollment performance, while maintaining strong protocol compliance and data quality standards throughout the study lifecycle.

“Sites initiated screening activity within the first weeks of activation”

REDUCED MONITORING BURDEN

Our centralized oversight model optimizes study supervision across all affiliated sites, reducing monitoring burden for sponsors and CROs while strengthening protocol compliance, ensuring operational consistency, and consistently delivering high-quality, reliable study outcomes.

Fewer Protocol Deviations

Standardized operational processes and continuous quality oversight across affiliated sites help minimize protocol deviations and ensure consistent protocol adherence throughout study execution.

Reliable Enrollment Forecasts

Our data-driven feasibility and patient-pool analytics enable realistic and dependable enrollment projections. By leveraging EMR-supported population insights and continuous site-level oversight, RMP provides sponsors with predictable recruitment timelines, reduced uncertainty, and greater confidence in study planning and execution.

SCALABLE MULTI-SITE EXECUTION

RMP’s embedded SMO model enables seamless execution of clinical trials across a network of integrated clinical sites through a unified operational infrastructure. Acting as a single point of coordination for sponsors and CROs, RMP delivers centralized governance, ensuring consistent quality control and standardized study execution across all participating sites.

Our integrated framework aligns sites under a common set of SOPs, centralized oversight, and real-time operational visibility. This approach minimizes start-up variability, accelerates site readiness, and enables efficient study scaling across a high-performing network—while maintaining the highest standards of protocol compliance, data integrity, and patient safety.

Study Start-Up & Operational Capabilities

Research Management Partners (RMP) maintains a structured operational framework designed to support efficient clinical trial activation and consistent study execution across our affiliated research sites.

Through centralized oversight and standardized operational procedures, our team works closely with investigators and site staff to ensure smooth study start-up and reliable study conduct.

Operational Capabilities

• Rapid feasibility response and sponsor communication
• Efficient regulatory document collection
• Standardized study start-up procedures across network sites
• Centralized oversight of study conduct and protocol compliance
• Support for investigator training and study preparation
• Continuous monitoring of operational performance across sites

Our embedded SMO structure allows RMP to deliver predictable activation timelines, strong site engagement, and consistent study performance for sponsors and CRO partners.

Collective Clinical Trial Execution Experience

At Research Management Partners (RMP), our operational model is built on more than structure—it is grounded in real-world clinical trial execution across multiple therapeutic areas, study phases, and site environments.

While RMP operates as an integrated SMO, the strength of our network comes from the collective experience of our investigators, sub-investigators, and operational leadership, all of whom have been directly involved in the delivery of clinical trials under real-world conditions.

Therapeutic & Operational Breadth

Our network has collectively supported clinical research across a wide range of indications, including but not limited to:

CNS and Psychiatry
Gastroenterology (including IBD)
Internal Medicine
Pulmonology
Nephrology
Dermatology
Women’s Health
Oncology (Radio-and-Hemato-oncology)
Biospecimen Collection

Across these therapeutic areas, our teams have contributed to:

Phase I–IV interventional trials
Biologic and small molecule studies
Complex protocol designs requiring strict compliance and patient retention strategies

Hands-On Execution Experience

Our investigators and study teams have served in key roles including:

Principal Investigator (PI)
Sub-Investigator (Sub-I)
Clinical Rater (including CNS-certified raters)
Study Coordinators and Regulatory Staff

This experience is not theoretical—it reflects direct involvement in patient recruitment, protocol adherence, data capture, adverse event management, and audit readiness.

Operational Leadership with Site-Level Insight

RMP’s operational leadership brings hands-on experience from high-volume clinical research environments, with direct exposure to:

Study start-up and regulatory coordination
On-site patient flow and retention dynamics
Source documentation and ALCOA-compliant data practices
Real-time issue identification and resolution

This allows us to anticipate operational risks before they impact timelines or data quality, rather than reacting after deviations occur.

From Individual Experience to System-Level Execution

What differentiates RMP is not only the experience within each site—but how that experience is standardized, supervised, and continuously optimized across the network.

We do not rely on isolated site performance.
We implement a controlled execution model that ensures:

Consistency across sites
Reduced variability in study conduct
Early detection of compliance drift
Predictable enrollment and retention performance

Execution Confidence Without Variability

Even as a growing SMO, our foundation is built on teams that have already operated within the realities of clinical trials.

Our role is to transform that experience into a unified, inspection-ready system—delivering the consistency sponsors require and the execution reliability they rarely find across independent sites.

Detailed investigator CVs and site-specific experience are available upon request or during feasibility discussions.

How RMP Executes Clinical Trials (Step-by-Step)

At RMP, execution is not left to individual site variability.
We implement a structured, repeatable operational model designed to ensure consistency, compliance, and predictable performance across all participating sites.

Below is how we operationalize every study from feasibility through execution:

1. Centralized Feasibility & Site Selection

We do not rely on passive feasibility responses.

Each opportunity is internally assessed using:

Real patient access data from affiliated practices
Investigator experience alignment
Operational readiness and staff availability

Only sites that meet both clinical and operational criteria are advanced—reducing downstream delays and screen failures.

2. Standardized Start-Up & Regulatory Alignment

Once selected, sites are aligned under a unified start-up framework:

Central coordination of regulatory documentation
SOP alignment with protocol-specific requirements
Pre-activation readiness checks

This approach reduces variability and supports accelerated timelines from IRB approval to SIV.

3. On-Site Operational Deployment

RMP operates within the site environment—not externally.

We ensure:

Study staff are trained and aligned with protocol expectations
Workflow integration with existing clinical operations
Clear delegation and role accountability

This embedded model allows for real-time oversight and immediate issue resolution.

4. Continuous Quality Control & Oversight

Execution does not rely on periodic monitoring alone.

We implement:

Ongoing on-site quality control reviews
Source data verification practices aligned with ALCOA principles
Early detection of protocol deviations and documentation gaps

This reduces query rates, minimizes rework, and maintains audit readiness throughout the study lifecycle.

5. Real-Time Operational Visibility

Through integrated platforms (e.g., CTMS, EHR-connected systems), we maintain:

Live tracking of enrollment and screening activity
Data entry and query resolution status
Site-level performance metrics

This enables proactive management rather than reactive correction.

6. Enrollment & Retention Management

Patient engagement is actively managed—not left to chance.

Our approach includes:

Leveraging existing patient populations within affiliated practices
Coordinated scheduling and follow-up processes
Retention-focused patient communication workflows

This supports consistent enrollment and reduces dropout risk.

7. Early Risk Identification & Rapid Intervention

Operational issues are addressed before they escalate.

We continuously monitor for:

Enrollment underperformance
Protocol deviations trends
Documentation inconsistencies

Corrective actions are implemented immediately at the site level, ensuring timeline protection and data integrity.

8. Sponsor-Facing Coordination & Accountability

RMP serves as a single operational interface across sites.

We provide:

Centralized communication with sponsors and CROs
Consolidated performance visibility
Alignment across all participating sites

This reduces sponsor oversight burden while improving execution consistency.

Controlled Execution. Predictable Performance.

RMP does not depend on individual site variability.
We apply a system-driven execution model that transforms independent sites into a coordinated, high-performing research network.

When Studies Underperform — How RMP Intervenes

Location

Miami, Florida.

Phone

786-464-0868

Email

Admin@RMPSMO.com

Contact us to learn how our integrated site network and centralized oversight model help Sponsors and CROs execute studies with speed, quality, and predictable outcomes.